Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

7.6%

13 terminated/withdrawn out of 171 trials

Success Rate

88.7%

+2.2% vs industry average

Late-Stage Pipeline

18%

30 trials in Phase 3/4

Results Transparency

4%

4 of 102 completed trials have results

Key Signals

12 recruiting4 with results12 terminated

Enrollment Performance

Analytics

N/A
85(65.9%)
Phase 4
27(20.9%)
Phase 2
9(7.0%)
Phase 1
4(3.1%)
Phase 3
3(2.3%)
Early Phase 1
1(0.8%)
129Total
N/A(85)
Phase 4(27)
Phase 2(9)
Phase 1(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (171)

Showing 20 of 171 trials
NCT07552636Not Yet Recruiting

Disease Activity Monitoring in Patients With Giant Cell Arteritis Study

Role: collaborator

NCT07268326Not ApplicableRecruiting

Plant-Based Diet for Patients With Rheumatoid Arthritis

Role: collaborator

NCT07442773Not ApplicableRecruiting

Intervention to Support Partners and Informal Caregivers of Frail RA-patients

Role: lead

NCT06533423Not ApplicableRecruiting

Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA Trial

Role: lead

NCT07318129Not ApplicableRecruiting

Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis

Role: lead

NCT04105231Phase 2Active Not Recruiting

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

Role: collaborator

NCT06895863Not ApplicableRecruiting

COpenhagen Magnetic Personalized Accelerated Brain Circuit Therapy for Treatment Resistant Depression

Role: collaborator

NCT05913947Phase 4Recruiting

Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)

Role: collaborator

NCT06993831Not ApplicableCompleted

ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia

Role: collaborator

NCT06624462Not ApplicableRecruiting

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Role: collaborator

NCT07105514Not ApplicableRecruiting

Indole-3-PROpionic Acid Clinical Trials - a Pilot Study Part 2

Role: lead

NCT03778554Phase 4Active Not Recruiting

Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction

Role: collaborator

NCT06152588Not ApplicableRecruiting

Restricted Eating Time in the Treatment of Type 2 Diabetes

Role: collaborator

NCT04160286Completed

The Danish Neuropsychological Study of the Adverse Effects of ECT

Role: collaborator

NCT06674018Not ApplicableCompleted

Indole-3-PROpionic Acid Clinical Trials - a Pilot Study

Role: lead

NCT06147232Phase 2Not Yet Recruiting

Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

Role: collaborator

NCT06792422Phase 4Recruiting

A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma

Role: lead

NCT02088060Phase 2Terminated

A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients

Role: collaborator

NCT06243172Unknown

Determining Circadian Metabolic and Behavioural Rhythms in Patients with and Without Type 2 Diabetes

Role: collaborator

NCT02132702Not ApplicableCompleted

Performance Attributes and User Progression While Using Ekso

Role: collaborator